MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Arterial Disease Multifactorial Intervention Trial (ADMIT)

Phase 3
Completed
Conditions
Heart Diseases
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Diabetes Mellitus
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000539

Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Phase 3
Completed
Conditions
Heart Failure, Congestive
Heart Diseases
Death, Sudden, Cardiac
Heart Failure
Arrhythmia
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000609

Nocturnal Oxygen Therapy

Phase 3
Completed
Conditions
Lung Diseases
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
First Posted Date
1999-10-28
Last Posted Date
2005-06-24
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000564

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)

Phase 3
Completed
Conditions
Lung Diseases
Pulmonary Embolism
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000566

Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)

Phase 3
Completed
Conditions
Hemoglobinopathies
Hematologic Diseases
Anemia, Sickle Cell
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000586

Antiarrhythmics Versus Implantable Defibrillators (AVID)

Phase 3
Completed
Conditions
Death, Sudden, Cardiac
Cardiovascular Diseases
Heart Diseases
Ventricular Fibrillation
Arrhythmia
Tachycardia, Ventricular
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000531

National Emphysema Treatment Trial (NETT)

Phase 3
Completed
Conditions
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
Emphysema
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000606

Activity Counseling Trial (ACT)

Phase 3
Completed
Conditions
Heart Diseases
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000551

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Myocardial Ischemia
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000478

Penicillin Prophylaxis in Sickle Cell Disease (PROPS)

Phase 3
Completed
Conditions
Hemoglobinopathies
Pneumonia
Anemia, Sickle Cell
Hematologic Diseases
Infection (S. Pneumoniae)
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000585
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy